# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Clearmind Medicine filed an international patent for a treatment that aims to enhance addiction treatment safety and efficacy.
Reported August 28: SciSparc Files For Sale Of Up To 21M Ordinary Shares Under $20M SEPA Agreement; Shares Priced At 97% Of Mar...
SciSparc would be entitled to receive consideration valued at $3 million in Polyrizon securities, as well as potential mileston...